Polyamines (putrescine and spermidine) are small-cationic amines ubiquitous in nature and present in most living cells. In recent years they have been linked to virulence of several human pathogens including Shigella spp and Salmonella enterica serovar Typhimurium (S. Typhimurium). Central to S. Typhimurium virulence is the ability to survive and replicate inside macrophages and resisting the antimicrobial attacks in the form of oxidative and nitrosative stress elicited from these cells. In the present study, we have investigated the role of polyamines in intracellular survival and systemic infections of mice. Using a S. Typhimurium mutant defective for putrescine and spermidine biosynthesis, we show that polyamines are essential for coping with reactive nitrogen species, possibly linking polyamines to increased intracellular stress resistance. However, using a mouse model defective for nitric oxide production, we find that polyamines are required for systemic infections independently of host-produced reactive nitrogen species. To distinguish between the physiological roles of putrescine and spermidine, we constructed a strain deficient for spermidine biosynthesis and uptake, but with retained ability to produce and import putrescine. Interestingly, in this mutant we observe a strong attenuation of virulence during infection of mice proficient and deficient for nitric oxide production suggesting that spermidine, specifically, is essential for virulence of S. Typhimurium.
Gastric cancer (GC) is a significant cancer-related cause of death worldwide. The most used chemotherapeutic regimen in GC is based on platinum drugs such as cisplatin (CDDP). However, CDDP resistance reduces advanced GC survival. In vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize new models of CDDP-resistant GC cell lines (AGS R-CDDP and MKN-28 R-CDDP) obtained through a stepwise increasing drug doses method, in order to understand the molecular mechanisms underlying chemoresistance as well as identify new therapeutic targets for the treatment of GC. Cell viability assays, cell death assays and the expression of resistance molecular markers confirmed that AGS R-CDDP and MKN-28 R-CDDP are reliable CDDP-resistant models. RNA-seq and bioinformatics analyses identified a total of 189 DEGs, including 178 up-regulated genes and 11 down-regulated genes, associated mainly to molecular functions involved in CDDP-resistance. DEGs were enriched in 23 metabolic pathways, among which the most enriched was the inflammation mediated by chemokine and cytokine signaling pathway. Finally, the higher mRNA expression of SERPINA1, BTC and CCL5, three up-regulated DEGs associated to CDDP resistance found by RNA-seq analysis was confirmed. In summary, this study showed that AGS R-CDDP and MKN-28 R-CDDP are reliable models of CDDP resistance because resemble many of resistant phenotype in GC, being also useful to assess potential therapeutic targets for the treatment of gastric cancers resistant to CDDP. In addition, we identified several DEGs associated with molecular functions such as binding, catalytic activity, transcription regulator activity and transporter activity, as well as signaling pathways associated with inflammation process, which could be involved in the development of CDDP resistance in GC. Further studies are necessary to clarify the role of inflammatory processes in GC resistant to CDDP and these models could be useful for these purposes.
Background and Objectives: Malaria is a disease that can result in a variety of complications. Diagnosis is carried out by an optical microscope and depends on operator experience. The use of artificial intelligence to identify morphological patterns in erythrocytes would improve our diagnostic capability. The object of this study was therefore to establish computer viewing models able to classify blood cells infected with Plasmodium spp. to support malaria diagnosis by optical microscope. Materials and Methods: A total of 27,558 images of human blood sample extensions were obtained from a public data bank for analysis; half were of parasite-infected red cells (n = 13,779), and the other half were of uninfected erythrocytes (n = 13,779). Six models (five machine learning algorithms and one pre-trained for a convolutional neural network) were assessed, and the performance of each was measured using metrics like accuracy (A), precision (P), recall, F1 score, and area under the curve (AUC). Results: The model with the best performance was VGG-19, with an AUC of 98%, accuracy of 93%, precision of 92%, recall of 94%, and F1 score of 93%. Conclusions: Based on the results, we propose a convolutional neural network model (VGG-19) for malaria diagnosis that can be applied in low-complexity laboratories thanks to its ease of implementation and high predictive performance.
Rett syndrome is a monogenic disorder with an incidence of 95% in women, characterized by the complexity of studying the associated phenotype due to the heterogeneity in patient tissues from the stochastic silencing of the affected X chromosome. Furthermore, we are largely unaware of the cascade of alterations that occur in neurons due to transcriptional changes induced by the affected MECP2 gene. To address these challenges, an in-depth network analysis was implemented using organoid single-cell transcriptomic data derived from human patients. We performed a Weighted correlation network analysis and trajectory analysis to understand the differences in the developmental processes between samples, we followed by the generation of gene regulatory networks for each relevant cell developmental pathways to assess the master regulator that are involved in this process, with the differential expressed genes with potential therapeutic implications being identified by integration with SFARI and Genes4Epi. The results were adapted into dynamic Boolean models fitted with the transcriptomic data for validation in which we evaluated the attractor field from each reachable state. These approaches allowed us to explore differences in regulatory behavior in the developmental pathways. Our study provides an insight that pinpoints the cellular stages on which the regulation and compensatory mechanism activate and regulate Rett syndrome. We identified 19 Master regulators for the Dopaminergic developmental trajectory, as well as 34 Master regulator genes for the Gabaergic developmental trajectory. Dynamic Boolean modeling of these systems showcased a comprehensive understanding of the disrupted developmental pathways of Rett syndrome, highlighting the transitional states of potential within maturation trajectories as the key point of divergence in regulation for Rett syndrome. After complementing with enrichment and clinical relevant variant analysis, we identify the key actors in this system as NR2F1 and TCF4, with TCF4 suggesting a symmetrical compensatory relationship with MeCP2, and NR2F1 as possible link with wider developmental conditions, this concluded with highlighting the possibility of regulation in this condition being affected by the MAPK-ERK pathway of transcriptional regulation, offering a novel angle for targeted research.